Patricia R. Robuck

7.4k total citations · 2 hit papers
21 papers, 4.0k citations indexed

About

Patricia R. Robuck is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Patricia R. Robuck has authored 21 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Patricia R. Robuck's work include Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Patricia R. Robuck is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Patricia R. Robuck collaborates with scholars based in United States, Belgium and Canada. Patricia R. Robuck's co-authors include Jay H. Hoofnagle, Aynur Ünalp, Arun J. Sanyal, Kris V. Kowdley, David E. Kleiner, James Tonascia, Elizabeth M. Brunt, Joel E. Lavine, Brent A. Neuschwander‐Tetri and Jeanne M. Clark and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Patricia R. Robuck

21 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

2010 2.5k citations Arun J. Sanyal, Naga Chalasani et al. New England Journal of Medicine profile →
Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

2009 431 citations William M. Lee, Linda S. Hynan et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia R. Robuck United States	16	2.9k	1.6k	1.4k	881	473	21	4.0k
Bilal Hameed United States	24	4.1k 1.4×	2.5k 1.5×	1.3k 0.9×	1.2k 1.4×	857 1.8×	70	5.7k
Carol Sargeant United States	12	3.5k 1.2×	1.5k 0.9×	1.7k 1.2×	851 1.0×	728 1.5×	17	4.2k
Paola Loria Italy	45	4.4k 1.5×	1.9k 1.2×	1.9k 1.4×	1.5k 1.8×	778 1.6×	112	6.4k
Tracey G. Simon United States	38	3.6k 1.2×	2.0k 1.3×	1.2k 0.8×	686 0.8×	556 1.2×	109	5.0k
George Cholankeril United States	31	3.0k 1.0×	1.8k 1.1×	874 0.6×	604 0.7×	373 0.8×	145	4.0k
Nicola Carulli Italy	34	2.1k 0.7×	908 0.6×	805 0.6×	1.4k 1.5×	618 1.3×	115	4.1k
Terry Gramlich United States	14	3.1k 1.1×	1.5k 0.9×	1.4k 1.0×	541 0.6×	200 0.4×	22	3.5k
Janus P. Ong United States	31	5.5k 1.9×	2.9k 1.8×	2.1k 1.5×	1.1k 1.3×	501 1.1×	72	6.3k
Shivakumar Chitturi Australia	25	4.4k 1.5×	1.5k 0.9×	2.1k 1.5×	745 0.8×	766 1.6×	40	5.5k
Mario Masarone Italy	29	1.9k 0.6×	939 0.6×	660 0.5×	291 0.3×	442 0.9×	93	2.9k

Countries citing papers authored by Patricia R. Robuck

Since Specialization

Citations

This map shows the geographic impact of Patricia R. Robuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia R. Robuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia R. Robuck more than expected).

Fields of papers citing papers by Patricia R. Robuck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia R. Robuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia R. Robuck. The network helps show where Patricia R. Robuck may publish in the future.

Co-authorship network of co-authors of Patricia R. Robuck

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia R. Robuck. A scholar is included among the top collaborators of Patricia R. Robuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia R. Robuck. Patricia R. Robuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brawman‐Mintzer, Olga, Valerie Durkalski, Qi Wu, et al.. (2014). Psychosocial Characteristics and Pain Burden of Patients With Suspected Sphincter of Oddi Dysfunction in the EPISOD Multicenter Trial. The American Journal of Gastroenterology. 109(3). 436–442. 20 indexed citations

Sundaram, Shikha S., Estella M. Alonso, Barbara Haber, et al.. (2013). Health Related Quality of Life in Patients with Biliary Atresia Surviving with their Native Liver. The Journal of Pediatrics. 163(4). 1052–1057.e2. 41 indexed citations

Shneider, Benjamin L., John Magee, Jorge A. Bezerra, et al.. (2012). Efficacy of Fat-Soluble Vitamin Supplementation in Infants With Biliary Atresia. PEDIATRICS. 130(3). e607–e614. 66 indexed citations

Shneider, Benjamin L., Bob Abel, Barbara Haber, et al.. (2012). Portal Hypertension in Children and Young Adults With Biliary Atresia. Journal of Pediatric Gastroenterology and Nutrition. 55(5). 567–573. 71 indexed citations

Rodrigue, James R., William F. Balistreri, Barbara Haber, et al.. (2011). Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Hepatology. 53(5). 1468–1475. 18 indexed citations

Cotton, Peter B., Valerie Durkalski, Olga Brawman‐Mintzer, et al.. (2010). Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointestinal Endoscopy. 72(5). 986–991. 10 indexed citations

Sanyal, Arun J., Naga Chalasani, Kris V. Kowdley, et al.. (2010). Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. New England Journal of Medicine. 362(18). 1675–1685. 2468 indexed citations breakdown →

Schwarz, Kathleen B., Regino P. González‐Peralta, Karen F. Murray, et al.. (2010). The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C. Gastroenterology. 140(2). 450–458.e1. 87 indexed citations

Rodrigue, James R., William F. Balistreri, Barbara Haber, et al.. (2009). Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes. Journal of Pediatric Gastroenterology and Nutrition. 48(3). 341–347. 91 indexed citations

10.

Lee, William M., Linda S. Hynan, Lorenzo Rossaro, et al.. (2009). Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure. Gastroenterology. 137(3). 856–864.e1. 431 indexed citations breakdown →

11.

Lavine, Joel E., Jeffrey B. Schwimmer, Jean P. Molleston, et al.. (2009). Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemporary Clinical Trials. 31(1). 62–70. 65 indexed citations

12.

Chalasani, Naga P., Arun J. Sanyal, Kris V. Kowdley, et al.. (2008). Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemporary Clinical Trials. 30(1). 88–96. 135 indexed citations

13.

Murray, Karen F., James R. Rodrigue, Regino P. González‐Peralta, et al.. (2007). Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. Clinical Trials. 4(6). 661–673. 25 indexed citations

14.

Sokol, Ronald J., Ross W. Shepherd, Riccardo Superina, et al.. (2007). Screening and outcomes in biliary atresia. Hepatology. 46(2). 566–581. 181 indexed citations

15.

DeRusso, Patricia A., Wen Ye, Ross W. Shepherd, et al.. (2007). Growth failure and outcomes in infants with biliary atresia: A report from the Biliary Atresia Research Consortium. Hepatology. 46(5). 1632–1638. 73 indexed citations

16.

Goodman, Zachary, Hala R. Makhlouf, Li Liu, et al.. (2007). Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial. Hepatology. 47(3). 836–843. 128 indexed citations

17.

Smith, Scott R., Abdus S. Wahed, Stephanie Kelley, et al.. (2007). Assessing the Validity of Self-Reported Medication Adherence in Hepatitis C Treatment. Annals of Pharmacotherapy. 41(7-8). 1116–1123. 44 indexed citations

18.

Tremaine, William J., et al.. (2005). Ethical Issues, Safety, and Data Integrity in Clinical Trials. Inflammatory Bowel Diseases. 11. S17–S21. 2 indexed citations

19.

Robuck, Patricia R. & John I. Wurzelmann. (2005). Understanding the Drug Development Process. Inflammatory Bowel Diseases. 11. S13–S16. 11 indexed citations

20.

Sandler, Robert S., James D. Lewis, Patricia R. Robuck, & Bruce E. Sands. (2005). Funding and Grantsmanship. Inflammatory Bowel Diseases. 11. S34–S37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact